John Wilkinson > Cooley (UK) LLP > London, England > Lawyer Profile
Cooley (UK) LLP Offices
22 Bishopsgate
LONDON
EC2N 4BQ
England
- Firm Profile
- Go to...
John Wilkinson
Work Department
Emerging Companies
Health Care
Intellectual Property
Life Sciences
Life Sciences Corporate Partnering & Licensing
Medical Devices
Mergers & Acquisitions
Public Companies
Position
John Wilkinson is partner in Cooley’s London office and his practice focuses primarily on the life sciences sector, advising pharmaceutical, biotechnology and medical technology companies on a wide range of IP, regulatory, antitrust and transactional matters. Amongst other things, John’s practice has involved a number of highly complex alliances and joint ventures, co-promotional and co-marketing arrangements, distribution and supply agreements, together with the operational, IP, antitrust and regulatory issues relating to such transactions.
Before qualifying as a lawyer, John obtained a degree in chemistry from Imperial College of Science Technology and Medicine and spent five years in the chemical and pharmaceutical industry working in drug development and other areas.
John advises pharmaceutical and biotechnology companies in the US, Canada, UK, Denmark, Hungary, Switzerland, Portugal, Sweden and Norway.
Career
Prior to joining Cooley, John was a partner at Reed Smith and previously at Bird & Bird. Prior to that, he was Legal Counsel at Cancer Research Technology Limited.
Before qualifying as a lawyer, John obtained a degree in chemistry from Imperial College of Science Technology and Medicine and spent five years in the chemical and pharmaceutical industry working in drug development and other areas.
Education
- College of Law, Chester
MAC Law Society Finals, 1993 - Imperial College
BS Chemistry, 1986
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
The team at Cooley (UK) LLP is jointly overseen by John Wilkinson, known for his prowess in handling large-scale alliances and joint ventures, and Nicola Maguire, who handles a range of IP and transactional issues such as high-profile collaborations and strategic investments. Transactional work is a mainstay of the practice with series investments and debt and equity financings notable areas of activity. Colm Murphy is geared to assist life sciences clients with their IP strategy, while Frances Stocks Allen excels in handling the IP aspects of major life sciences deals. Joe Sandys further extends the unit’s transactional expertise and frequently advises on licensing and M&A matters.
Lawyer Rankings
Top Tier Firm Rankings
- Industry focus > TMT
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Insurance > Product liability: defendant
Firm Rankings
- Industry focus > Life sciences and healthcare
- Dispute resolution > Public international law
- Corporate and commercial > Venture capital
- Employment > Employee share schemes
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > Equity capital markets – mid-large cap
- TMT (technology, media and telecoms) > Fintech: corporate and commercial
- TMT (technology, media and telecoms) > Fintech: regulatory
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Corporate and commercial > Corporate tax
- Risk advisory > Data protection, privacy and cybersecurity
- Crime, fraud and licensing > Fraud: civil
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Dispute resolution > International arbitration
- Employment > Employers
- Corporate and commercial > EU and competition